Search Results

240 results for lsi

Market Analysis – Don’t Get Bitten by a Dead Cat Bounce

We may see a bounce late today or tomorrow, but investors who buy into it will likely get burned.

Didn’t Anyone See the Bubble Coming?

The market bubble was a long time in coming, but reading through the tea leaves requires foresight and someone to finally shout out the obvious.

Biggest Movers in Retail Trade Stocks Now – LITB BSI SSI SVU

The Retail Trade sector saw plenty of trading activity today, including the following leaders and losers.

5 Best ETFs Right Now

The best ETFs so far in 2015 include some lesser-known funds dealing in niches like small-cap health care and Japanese financials.

Surprise! These 3 Dividend Giants Are at 52-Week Lows. Buy Them Before They Soar

Buying dividend giants at 52-week lows is a smart investment strategy to generate the greatest returns when they rebound.

QSI Stock Earnings: Quantum-Si Beats EPS, Beats Revenue for Q1 2024

QSI stock results show that Quantum-Si beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

The New Nifty Fifty

Long-term investors may find opportunities in this group of largely household names — with steady earnings and often above-average dividends.

Food and Beverage Stocks Look Appetizing After Ozempic Selloff

Investors should brush off Ozempic selloff fears and dive into tasty food and beverage stocks that have been oversold in 2023.

Tough Market? Not for Defensive Stocks

The market has been hit hard since the start of April, but not all sectors have lost ground. Find out what has been working through…

Industry Group Rank Limits Eli Lilly (LLY) Rating

The current recommendation of Hold for Eli Lilly and Company (NYSE:LLY) is computed using the methodology for investing of Louis Navellier and his Portfolio Grader…

Eli Lilly (LLY) a Hold on Anemic Earnings Momentum

Portfolio Grader currently ranks Eli Lilly and Company (NYSE:LLY) a Hold. The methods for fundamental and quantitative metrics used in this analytical tool, developed by…

Industry Group Rank Restrict Eli Lilly (LLY) Rating

Eli Lilly and Company (NYSE:LLY) ranks in the top 10% of its industry group, Pharmaceuticals, and in the top decile of sector group, Health Care,…

Hold Ranking on Eli Lilly (LLY) Shares Confirmed

Portfolio Grader currently ranks Eli Lilly and Company (NYSE:LLY) a Hold. The approach to fundamental and quantitative metrics used in this analytical tool, developed by…

Analytics for Quant Score Drive Upgrade of Eli Lilly (LLY) to Buy

The current recommendation of Buy for Eli Lilly and Company (NYSE:LLY) is the result of using Louis Navellier’s Portfolio Grader stock evaluator, which incorporates his…

Trade of the Day: Eli Lilly (LLY)

We are opening a new bullish trade on Eli Lilly (NYSE:LLY), the $106 billion manufacturer of pharmaceutical products. LLY skyrocketed higher after its last earnings…

Eli Lilly’s (LLY) Upgraded to Buy

Eli Lilly and Company (NYSE:LLY) is one of 134 companies within the Pharmaceuticals GICS industry group, which is in turn part of the 781 company…

Eli Lilly (LLY) Industry Group Rank Limit Rating

With a $92.0 billion market value, Eli Lilly and Company (NYSE:LLY) ranks in the top decile in its industry group, Pharmaceuticals, and in the top…

Solid Quant Score Keep Eli Lilly (LLY) a Buy

Eli Lilly and Company (NYSE:LLY) is ranked as a Buy using the Portfolio Grader stock evaluator, which incorporates Louis Navellier’s investing methodology. This represents no…

A Bitter 2015 Bodes a Sweet 2016 for Hershey (HSY)

Hershey is transitioning for the long term with a switch to all-natural, higher-end ingredients, which makes HSY stock is a sweet pick.

Eli Lilly (LLY) Shares a Strong Sell at $77.02

Eli Lilly (LLY) a Strong Sell at $77.02 based on the most current relative pricing of its shares and analysis.

FSI Stock: The Hidden Gem of the Green Wave Revolution

Although risky and under-the-radar, if it successfully capitalizes on green trends, FSI stock could really take off in price over time.

LLY Stock: Eli Lilly Is Healthy as a Horse

LLY is on a rampage this month delivering profits aplenty to shareholders. Here’s how to play the continued LLY stock rise with options.

Eli Lilly (LLY) Hold Ranking Retained

Eli Lilly and Company (NYSE:LLY) is ranked as a Hold using the methods for investing of Louis Navellier and his Portfolio Grader stock evaluator. LLY…

One Stock to Cut Through the AI Noise

The data seemed clear – but that doesn’t mean the conclusions were. During World War II, U.S. military analysts examined bombers that had safely returned…

10 – 10 of 240 results